These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6873753)

  • 41. The effects of aminoglycoside antibiotics on platelet aggregation and blood coagulation.
    Chen G; Fei X; Ling J
    Clin Appl Thromb Hemost; 2012 Sep; 18(5):538-41. PubMed ID: 22327814
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelets provide robustness of spatial blood coagulation to the variation of initial conditions.
    Balandina AN; Koltsova EM; Shibeko AM; Kuprash AD; Budkova VA; Demina IA; Ignatova AA; Fadeeva OA; Vijay R; Nair SC; Srivastava A; Shi Q; Ataullakhanov FI; Panteleev MA
    Thromb Res; 2023 Oct; 230():133-143. PubMed ID: 37717370
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulation of heparin cofactor II activity by histidine-rich glycoprotein and platelet factor 4.
    Tollefsen DM; Pestka CA
    J Clin Invest; 1985 Feb; 75(2):496-501. PubMed ID: 3838317
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of rivaroxaban, in contrast to heparin, is similar in neonatal and adult plasma.
    Novak M; Schlagenhauf A; Bernhard H; Schweintzger S; Leschnik B; Muntean W
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):588-92. PubMed ID: 21799400
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.
    De Cristofaro R; De Filippis V
    Biochem J; 2003 Jul; 373(Pt 2):593-601. PubMed ID: 12689334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemically modified thrombin and anhydrothrombin that differentiate macromolecular substrates of thrombin.
    Hosokawa K; Ohnishi T; Kawakami A; Wakabayashi S; Koide T
    J Thromb Haemost; 2005 Dec; 3(12):2703-11. PubMed ID: 16246253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of fibrin clot formation by human serum amyloid P component (SAP) and heparin.
    Ku CS; Fiedel BA
    J Exp Med; 1983 Sep; 158(3):767-80. PubMed ID: 6886628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro effects of recombinant activated factor VII on thrombin generation and coagulation following inhibition of platelet procoagulant activity by prasugrel.
    Mazzeffi M; Szlam F; Jakubowski JA; Tanaka KA; Sugidachi A; Levy JH
    Thromb Res; 2013 Jul; 132(1):106-11. PubMed ID: 23664633
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro effect of the potent poly(ADP-ribose) polymerase (PARP) inhibitor INO-1001 alone and in combination with aspirin, eptifibatide, tirofiban, enoxaparin or alteplase on haemostatic parameters.
    Tóth O; Szabó C; Kecskés M; Pótó L; Nagy A; Losonczy H
    Life Sci; 2006 Jun; 79(4):317-23. PubMed ID: 16480745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biochemical and pharmacological effects of the direct thrombin inhibitor AR-H067637.
    Deinum J; Mattsson C; Inghardt T; Elg M
    Thromb Haemost; 2009 Jun; 101(6):1051-9. PubMed ID: 19492147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelet involvement in the activated coagulation time of heparinized blood.
    Moorehead MT; Westengard JC; Bull BS
    Anesth Analg; 1984 Apr; 63(4):394-8. PubMed ID: 6367544
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of unfractionated and low-molecular-weight heparin on platelet aggregation and in vitro bleeding time in dogs].
    Nimmerfall K; Mischke R
    Dtsch Tierarztl Wochenschr; 1999 Oct; 106(10):439-44. PubMed ID: 10589154
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelet procoagulant activity is independent of aggregation.
    Rendu F; Lavie P; Saleun S; Lasne D
    Nouv Rev Fr Hematol (1978); 1995; 37(6):327-31. PubMed ID: 8907627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions.
    Hosokawa K; Ohnishi T; Miura N; Sameshima H; Koide T; Tanaka KA; Maruyama I
    Thromb Res; 2014 Jan; 133(1):66-72. PubMed ID: 24268424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets.
    Schols SE; Feijge MA; Lancé MD; Hamulyák K; ten Cate H; Heemskerk JW; van Pampus EC
    Transfusion; 2008 Nov; 48(11):2384-94. PubMed ID: 18673348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.
    Dumenco LL; Everson B; Culp LA; Ratnoff OD
    J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thrombin generation assay and viscoelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin.
    Tanaka KA; Szlam F; Sun HY; Taketomi T; Levy JH
    Anesth Analg; 2007 Oct; 105(4):933-9, table of contents. PubMed ID: 17898368
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coagulation Factor XI Promotes Distal Platelet Activation and Single Platelet Consumption in the Bloodstream Under Shear Flow.
    Zilberman-Rudenko J; Itakura A; Wiesenekker CP; Vetter R; Maas C; Gailani D; Tucker EI; Gruber A; Gerdes C; McCarty OJ
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):510-7. PubMed ID: 26769048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.